| ID | 1017 |
| Name of the vaccine | Decavac |
| Microbe | Bacteria |
| Disease name | Diphtheria |
| Name of bacteria | Corynebacterium diphtheriae |
| Type of vaccine | Combination |
| Nucleic acid content | DNA |
| Age | 7 years and older |
| Description of the vaccine | Tetanus and diphtheria toxoids adsorbed (Td vaccine). |
| Name of the manufacturer | Sanofi Pasteur Inc. |
| Name of the manufacturing country | United States |
| Year of manufacture | 1955 |
| Clinical Phase status | Approved |
| Bacterial strain | Gram-positive bacillus. |
| Efficacy | NA |
| Vaccine formulation | Sterile suspension |
| Dosage | Primary Immunization - three 0.5 mL doses.
Routine booster - in children 11-12 years of age and every 10 years. |
| Mechanism of action | Serum diphtheria antitoxin level-
0.01 IU/mL - lowest protection level.
0.1 IU/mL - Protective
Greater than or equal to 1.0 IU/mL - Long term protection |
| Route of administration | Intramuscular |
| Indications | Active immunization for the prevention of tetanus and diphtheria. |
| Export | NA |
| Approval | US FDA |
| Adjuvant | Alum |
| Repurposing | For tetanus also. |
| Side effects of vaccine | Pain, headache, injection site swelling and erythema, muscle weakness, tiredness, diarrhoea, chills, nausea, sore and swollen joints. |
| Post vaccination | NA |
| Dose type | Combination doses |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NA |
| Reference | https://www.rxlist.com/decavac-drug.htm#description |
| Other name | NA |
| Additional Links | NA
|